GHK
- Category
- Skin & Cosmetic
- Administration routes
- Topical
- Regulatory status
- Not FDA-approved
What it is
A naturally occurring copper-binding tripeptide marketed for wound healing, skin anti-aging, and anti-inflammatory effects via switching on thousands of genes in damaged tissue. Strongest evidence is animal and lab work on the copper-bound form (GHK-Cu); GHK alone has almost no human trials, no long-term safety data, and no established dosing. Supply is unregulated. Not an FDA-approved drug.
Read Full recordStudied uses & evidence
Studied uses(10)
Gene expression modulation (4,000+ genes)
LowDerived from one human cell-line gene expression dataset, mostly unvalidated experimentally.
Wound healing and tissue regeneration
SpeculativeShown for the related compound GHK-Cu, not directly tested for copper-free GHK in humans.
Anti-inflammatory action
LowReduces inflammatory markers in animal and cell studies, not yet tested in a human trial.
Evidence limits
- Evidence Level
- Limited Clinical
Over 50 years of research since 1973 discovery. Broad Institute gene profiling confirms modulation of 4,000+ genes. Multiple 12-week placebo-controlled human trials for topical skin applications (using GHK-Cu). Extensive animal wound healing data across 5+ species. Anti-cancer and COPD gene reversal data from genomic analyses. Cognitive improvement in aged mice. Most clinical human studies used the copper-complexed form (GHK-Cu); GHK alone has strong in vitro and genomic evidence but fewer standalone human trials.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
General cautions
Pregnancy or breastfeeding
AbsoluteNo human reproductive safety data exists for this peptide. Effects on fetal development are unknown.
Children under 18
AbsoluteNo pediatric safety data. Not recommended for use in minors.
Known hypersensitivity
AbsoluteDiscontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).
Risk summary(8)
Risks = level of concern: High · Moderate · Low · Theoretical
Very limited human clinical data for GHK alone (most studies use GHK-Cu copper complex)
HighResearch-grade GHK peptide may not meet pharmaceutical purity standards — quality varies among unregulated products sold online
ModerateSensitive to carboxypeptidase degradation, particularly in wound environments — rapid breakdown limits bioavailability
ModerateLong-term systemic safety data in humans is lacking (no large-scale injectable trials)
HighGene modulation data is primarily from Broad Institute Connectivity Map computational analysis, not all validated in vivo
HighGHK alone may have reduced efficacy compared to GHK-Cu for applications requiring copper delivery (antioxidant, wound healing)
ModerateNo standardized dosing protocols established for oral or injectable GHK (without copper) in humans
HighTheoretical concern: broad gene modulation (4,000+ genes) could have unintended effects not yet characterized
Theoretical
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.